Literature DB >> 7519165

Keratinocyte induced chemotaxis in the pathogenesis of Paget's disease of the breast.

C R de Potter1, I Eeckhout, A M Schelfhout, M L Geerts, H J Roels.   

Abstract

In Paget's disease of the breast, the epidermis contains large clear neoplastic cells. To explain the pathogenesis of this disease, the immunohistochemical characteristics of these cells were investigated in 25 patients. The cytoplasmic presence of low molecular weight cytokeratin and the absence of high molecular weight cytokeratin in all cases confirmed the glandular origin of the Paget cells. Membrane over-expression of the neu-protein was established in 96% of cases. It was hypothesized that epidermal keratinocytes release a chemotactic factor which attracts neu-over-expressing breast carcinoma cells by chemotaxis into the epidermis. The biological assays showed that normal keratinocytes release one or more chemotactic factor(s) into their conditioned medium, which induced spreading and motility of neu-over-expressing SK-BR-3 human breast cancer cells. The conditioned medium of keratinocytes also attracted the SK-BR-3 cells by chemotaxis in a modified Boyden chamber. Furthermore, MCF-7 human breast cancer cells, which do not over-express the neu-protein, were not attracted by chemotaxis of conditioned medium of human keratinocytes. The involvement of the neu-protein in spreading, motility and chemotaxis is further indicated by the inhibition of these processes by monoclonal antibodies against the extracellular domain of the neu-protein. We conclude, therefore, that the Paget cells spread through the epidermis due to the motility induced by a chemotactic factor, which is released by epidermal keratinocytes and whose influence is mediated by the neu-protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519165     DOI: 10.1111/j.1365-2559.1994.tb00536.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.

Authors:  M I Koukourakis; A Giatromanolaki; K J O'Byrne; J Cox; B Krammer; K C Gatter; A L Harris
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

2.  Proliferating activity in paget disease of the nipple.

Authors:  Jean-Christophe Noel; Isabelle Fayt; Frederic Buxant
Journal:  Pathol Oncol Res       Date:  2009-12-17       Impact factor: 3.201

Review 3.  The neu-protein and breast cancer.

Authors:  C R De Potter; A M Schelfhout
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  c-erbB-2 and the "triple-state" in early breast carcinomas.

Authors:  Efthimios Sivridis; Charilaos Stamos; Aliki Fiska; Nikolaos Nikolettos; Michael I Koukourakis; Alexandra Giatromanolaki
Journal:  Med Oncol       Date:  2009-06-23       Impact factor: 3.064

5.  Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.

Authors:  A Giatromanolaki; M I Koukourakis; E Sivridis; H Turley; K Talks; F Pezzella; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

6.  The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients.

Authors:  Isabella Castellano; Jasna Metovic; Davide Balmativola; Laura Annaratone; Nelson Rangel; Elena Vissio; Riccardo Arisio; Luigia Macrì; Carla Pecchioni; Ivana Sarotto; Francesca Montarolo; Francesca Muscarà; Caterina Marchiò; Paola Cassoni; Janina Kulka; Anna Sapino
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.